“There’s a lot of action in the brain, but what we were trying to argue in our paper is that there also is probably action in the gut,” says study co-author Alex DiFeliceantonio, an appetitive neuroscientist at Virginia Tech. “We need to look at both to really fully understand how these drugs are working to reduce the intake of substances with abuse liability.”